|1.||Cha, Hee-Jae: 10 articles (05/2014 - 11/2003)|
|2.||Castagnola, Massimo: 9 articles (06/2015 - 01/2011)|
|3.||Ock, Mee Sun: 9 articles (05/2014 - 11/2010)|
|4.||Moon, Eun-Yi: 8 articles (04/2015 - 06/2008)|
|5.||Jo, Jin-Ok: 8 articles (05/2014 - 11/2010)|
|6.||Kang, Yun-Jeong: 8 articles (05/2014 - 11/2010)|
|7.||Messana, Irene: 7 articles (06/2015 - 01/2011)|
|8.||Faa, Gavino: 6 articles (05/2015 - 02/2012)|
|9.||Ryu, Yun-Kyoung: 6 articles (04/2015 - 11/2010)|
|10.||Chopp, Michael: 6 articles (01/2015 - 01/2011)|
|1.||Chronic Hepatitis B
02/01/2008 - "Thymosin alpha-1 (Talpha1) is an immune modifier that has been shown to be effective for chronic hepatitis B (CHB) in some trials. "
06/01/2008 - "Thymosin alpha-1 (Talpha1) has been shown to be effective in chronic hepatitis B treatment. "
03/01/2002 - "Thymosin alpha is a safe and effective alternative treatment modality in chronic hepatitis B."
03/01/2002 - "Thymosin alpha in the treatment of chronic hepatitis B: an uncontrolled open-label trial."
09/01/1991 - "Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial."
09/01/1991 - "The results of this pilot trial suggest that thymosin therapy promotes disease remission and cessation of hepatitis B virus replication in patients with chronic viral infection."
01/01/1992 - "A preliminary report of a controlled study of thymosin alpha-1 in the woodchuck model of hepadnavirus infection."
01/01/1977 - "The thymus gland: recent studies relating to 'thymosin', ageing and 'slow' infection of the nervous system."
01/01/2015 - "Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro."
04/01/2002 - "Upregulation of thymosin beta-10 by Mycobacterium bovis infection of bovine macrophages is associated with apoptosis."
|3.||Nephrotic Syndrome (Syndrome, Nephrotic)
01/01/2004 - "Thymosin and TIAOJINING were also effective for reducing the risks of infection in children with nephrotic syndrome with RR 0.50 (95%CI 0.26 to 0.97) and 0.59 (95%CI 0.43 to 0.81) respectively. "
01/01/2004 - "IVIG, thymosin and TIAOJINING may have positive effects on prevention of nosocomial or unspecified infection with no obvious serious adverse events in children with nephrotic syndrome. "
01/01/2012 - "Thymosin (RR 0.50, 95% CI 0.26 to 0.97), oral transfer factor (RR 0.51, 95% CI 0.35 to 0.73), BCG vaccine injection (RR 0.68, 95% CI 0.48 to 0.95), Huangqi granules (RR 0.62, 95% CI 0.47 to 0.83) and TIAOJINING (RR 0.59, 95% CI 0.43 to 0.81) were also effective in reducing the risk of infection in children with nephrotic syndrome. "
01/01/2012 - "IVIG, thymosin, oral transfer factor, BCG vaccine, Huangqi granules and TIAOJINING may have positive effects on the prevention of nosocomial or unspecified infection with no obvious serious adverse events in children with nephrotic syndrome. "
09/01/2013 - "In the present study, the immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide (Tα1-TP5) was investigated in vivo. "
03/01/2011 - "The comparisons of the expression of thymosin β4 between the normal and tumor tissues are also needed to study the role of thymosin β4 in tumor formation. "
01/01/1983 - "Additional studies with repeated thymosin doses in more homogeneous cancer populations appear to be justified."
01/01/1983 - "Tumor responses were not seen, but the study suggested thymosin treatments would need to be repeated every 2-3 days to sustain an immune response. "
11/01/1978 - "Studies on the effect of thymosin on T-cell levels in vitro among normal persons and cancer patients show that, in general, T-cell levels increase after incubation with thymosin in populations with low initial T-cell levels while the levels decrease in populations with high initial T-cell levels. "
|5.||Neoplasm Metastasis (Metastasis)
07/01/2015 - "The present study aimed to measure the expression levels of thymosin β4 (Tβ4) in liver samples from patients with HB and to investigate the involvement of Tβ4 in HB metastasis. "
09/01/1983 - "A role for the thymus in metastasis via an endocrine product (thymosin) is suggested by these studies. "
01/01/2014 - "The actin-sequestering protein thymosin beta-4 (Tβ4) is involved in various cellular and physiological processes such as proliferation, motility, growth and metastasis. "
06/15/1993 - "Four non-metastatic cell lines, which produced no experimental liver metastasis in nude mice, showed high expression of thymosin beta-4. "
01/01/1984 - "Therapeutic protocols using thymosin F5 and directed against pre-existing experimental and spontaneous metastases, had a significant immunotherapeutic potential."
|1.||Hepatitis B e Antigens
|3.||Interferon-alpha (Interferon Alfa)
|5.||DNA (Deoxyribonucleic Acid)
|6.||Interleukin-10 (Interleukin 10)
|7.||Catalytic RNA (Ribozymes)
|8.||Ophthalmic Solutions (Eye Drops)
|10.||Transfer Factor (Factor, Transfer)
|3.||Drug Therapy (Chemotherapy)
|4.||Hematopoietic Stem Cell Transplantation